Research News

Research News | Jul. 21, 2014

Treat-to-Target in Lupus

An international group of lupus experts has developed a set of recommendations to implement the treat-to-target strategy for managing lupus.

Research News | Jan. 22, 2014

Study Finds Malaria Drug Combo Could Help Prevent Lupus Pregnancy Complications

Lupus Foundation of America supported study finds combination therapy that includes hydroxychloroquine may be beneficial to pregnant patients with lupus and/or antiphospholipid syndrome.

Research News | Jan. 09, 2014

New Tool Helps to Ensure Better Representation of Minorities in Future Lupus Quality of Life Studies

Researchers now have a cost effective tool to help them better understand the burden of disease among populations at high risk for developing lupus. Learn more.

Research News | Oct. 28, 2013

In Treatment Adherence Study, Many Medicaid Beneficiaries Struggled to Stay on Medications

Researchers from the University of California and Brigham and Women’s Hospital in Boston recently examined adherence among Medicaid beneficiaries with lupus to prescribed medications and found the patients were not following treatment plans, putting themselves at risk for poor outcomes.

Research News | Aug. 16, 2013

Adult Stems Cells in the Treatment of Lupus - Where are we now?

Cell based therapies are a growing interest in all areas of medicine as they are viewed as long term solutions rather than temporary fixes. A recent journal article highlights progress made in better understanding the potential for two basic types of adult stem cells.

Research News | Aug. 15, 2013

Pilot Study Sheds Light on a Potential New Approach for Treating Lupus Nephritis

Lupus nephritis, which can damage and scar the kidneys, is one of the most common and serious complications of lupus. This new study suggests that with the right induction regimen, it may be possible to avoid maintenance (long-term) treatment with oral steroids.

Research News | Jan. 10, 2013

Study explores lupus treatments and disease activity as risk factors for lymphoma

A new study sheds light on the specific effects of drug treatments versus disease activity as risk factors for lymphoma, a type of cancer, among people with lupus.

Research News | Nov. 08, 2012

Steroid-Related Risk of Heart Disease in Lupus

The results of this study indicate that current use of steroids (20 mg/day or more) is perhaps the most significant risk factor for heart disease in individuals with lupus.